A moderate intensity endurance and resistance exercise training program improves muscle performance in statin users without exacerbating muscle complaints. This is one of the conclusions of a training study that is published in the Journal of the American College of Cardiology (JACC). Cholesterol-lowering drugs (statins) are among the most widely prescribed medications in the world for prevention of cardiovascular diseases and are suggested to influence the exercise tolerance of its users.
Statins are well-tolerated, but may produce muscle symptoms (e.g. cramps, pain, fatigue, stiffness) in some patients, in part due to disturbed muscle mitochondrial energy metabolism. Physical activity is also associated with reduced cardiovascular disease risk, and this reduction is enhanced by statin treatment. It was, however, unclear if the mitochondrial dysfunction associated with statin therapy attenuates training adaptations and exacerbates muscle complaints with exercise training.
Patients with and without statin-associated muscle symptoms underwent a supervised training program for twelve weeks. The program consisted of endurance cycling training twice a week and resistance training once a week. Researchers of Radboud university medical center, Wageningen University & Research and Maastricht University measured muscle performance, muscle mitochondrial energy metabolism, muscle fiber capillarization and muscle symptoms before and after training.
Both symptomatic and asymptomatic statin users can improve skeletal muscle performance, muscle fiber capillarization and mitochondrial content by participating in a combined exercise training program without exacerbating symptoms. ‘This has important clinical implications’, says researcher Eline Allard of Radboud university medical center, ‘since combining statin therapy with physical activity is known to produce substantial health benefits.'
The results indicate that statin use is unlikely to alter the exercise training response and statin use should not be a factor limiting clinicians from prescribing exercise to statin users. Exercise training may even increase quality of life in symptomatic statin users.
Type 1 muscle fibers
The study outcome also opens new avenues for further research. The distribution of muscle fiber types may be an important factor for statin-associated muscle symptoms. ‘Type I muscle fibers, mainly used for endurance exercises, were less prevalent in symptomatic statin users before the training intervention’, says researcher Silvie Timmers of Wageningen University & Research. Further research is needed to examine whether increasing the proportion of type I muscle fibers by exercise training is an effective strategy to improve muscle performance in symptomatic statin users’.
About the publication in the Journal of the American College of Cardiology
Moderate Intensity Exercise Training Improves Skeletal Muscle Performance in Symptomatic and Asymptomatic Statin Users - Neeltje A.E. Allard, Lando Janssen, Thorben Aussieker, Anouk A.F. Stoffels, Richard J. Rodenburg, Willem J.J. Assendelft, Paul D. Thompson, Tim Snijders, Maria T.E. Hopman, and Silvie Timmers. J Am Coll Cardiol. 2021 Nov, 78 (21) 2023–2037.
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Yvonne Schoon appointed professor by special appointment 'The right care for the right older person'6 December 2021
Yvonne Schoon has been appointed professor by special appointment 'The right care for the right older person' at the Radboudumc / Radboud University as of 1 October 2021.read more
How much should we exercise to live healthier lives? Research into the relationship between exercise, heart disease and mortality3 December 2021
It has long been known that exercise reduces the risk of many chronic diseases. However, we do not yet know exactly how much exercise is necessary to achieve health benefit.read more
KNAW Early Career Award for Martine Hoogman2 December 2021
Martine Hoogman has been awarded a KNAW Early Career Award. The prize, a sum of 15,000 euros and a work of art, is aimed at researchers in the Netherlands who are at the start of their careers and have innovative, original research ideas.read more
T-Guard can reset immune system1 December 2021
For 20 years, the Nijmegen based Radboudumc spin-off company Xenikos has been working on a drug that can reset the immune system. This reset will save lives of seriously ill patients. Now, after years of hard work, the moment of truth has arrived for T-guard.read more
Thomas van den Heuvel wins Stairway to Impact Award for safer pregnancies using AI Award for safer pregnancies using AI1 December 2021
Radboudumc researcher Thomas van den Heuvel receives the Stairway to Impact Award from Dutch Research Council NWO. He receives this prize for the development of the BabyChecker, a smartphone application that allows midwives to make ultrasounds during pregnancies.read more